vedolizumab (entyvio) Report issue

Biologics mAb Approved FDA First in Class Fast Track FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$2407.4538

VA Big4

$4573.8400

VA FSS

$6255.2200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
vedolizumab 300 mg (INJECTION) $2407.4538 AUS PBS generic
  • Entyvio (1)
    		•  Takeda Pharmaceuticals Australia Pty Ltd
    vedolizumab 300 mg / 5 mL (5 mL INJECTION) $4573.8400 VA Big4
  • Entyvio (1)
    		•  Takeda Pharmaceuticals America, Inc.
    vedolizumab 300 mg / 5 mL (5 mL INJECTION) $6255.2200 VA FSS
  • Entyvio (1)
    		•  Takeda Pharmaceuticals America, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue